Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets.
D001741:Black or African American / Q000706:statistics & numerical data; D000367:Age Factors; D000961:Antilymphocyte Serum / Q000191:economics* / Q000627:therapeutic use; D044383:Black People; D002408:Catheters, Indwelling; D003928:Diabetic Nephropathies / Q000601:surgery; D004311:Double-Blind Method; D006084:Graft Rejection / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D010530:Peritoneal Dialysis; D014019:Tissue Donors